官方服务：
资源简介：
The supplement data about the validity of immunotherapy against palate mucoepidermoid carcinoma
应用场景：
相关数据集
ICI-5 Flow and Histology Data
Flow cytometry and histology data for ICI-5. PMBC data from day 21 will be published under separate dataset due to lack of storage. Rest of information is available on figshare (see link below).
NIAID Data Ecosystem40
Supporting the use of adjuvant radiotherapy in recurrent pleomorphic adenoma of the parotid
The use of adjuvant radiotherapy remains controversial in the treatment of recurrent pleomorphic adenomas. The aim of this study was to provide the highest level of evidence possible by performing a s
Taylor & Francis Group2023-04-19 更新20
Checkpoint immunotherapy is associated with preferential activation of tumor-antigen specific CD4+ T cells in MDS.
A growing body of literature suggests that the efficacy of DNA hypomethylating agents (HMAs) are mediated via activation of anti-tumor immune mechanisms. Based upon this hypothesis a series of early p
NIAID Data Ecosystem20
Effects of ferroptosis inducer FIN56 in HSC-3 HNSCC cells. Effects of ferroptosis inducer FIN56 in HSC-3 HNSCC cells
We treated ferroptosis inducer FIN56 (1uM,48hrs) in HSC-3 HNSCC cells. DMSO treatment as control cells group. Overall design: RNA sequencing of FIN56 (1uM,48hrs) treated HSC-3 HNSCC cells. DMSO treatm
NIAID Data Ecosystem30
DataSheet_1_Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis.csv
BackgroundAnti-programmed cell death protein 1 and its ligand (anti-PD1/PDL1) have been proposed as a promising therapeutic option for advanced biliary tract cancer (aBTC). Given the scarce quantitati
NIAID Data Ecosystem20
